Catalyst Wire Dossier Catalyst Wire Dossier

Merck HPV vaccine (multivalent HPV vaccine)

HPV vaccine · Merck Sharp & Dohme LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Merck HPV vaccine (multivalent HPV vaccine), covering 2015-03-09 to 2015-03-09. Get the full timeline:

Most recent: Clinical Trial Update: Multivalent HPV (Human Papillomavirus) Vaccine Study in 16- to 26-Year Old Men and Women (V503-003) [Phase 3]

See pricing